Delaware Bioscience Association Inc
Delaware Bioscience Association Inc shows consistent revenue growth and strong asset accumulation with no reported officer compensation.
EIN: 204147195 · Wilmington, DE · NTEE: S46 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $1.0M |
| Total Expenses | $647K |
| Program Spending | 80% |
| CEO/Top Officer Pay | $1 |
| Net Assets | $1.7M |
| Transparency Score | 90/100 |
Is Delaware Bioscience Association Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Delaware Bioscience Association Inc directs 80% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Delaware Bioscience Association Inc
Delaware Bioscience Association Inc (EIN: 204147195) is a nonprofit organization based in Wilmington, DE, classified under NTEE code S46. The organization reported total revenue of $1.0M and total assets of $2.1M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Delaware Bioscience Association Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Delaware Bioscience Association Inc is a mid-size nonprofit that has been operating for 20 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 11.3%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $986K |
| Total Expenses | $647K |
| Surplus / Deficit | +$339K |
| Total Assets | $2.0M |
| Total Liabilities | $270K |
| Net Assets | $1.7M |
| Operating Margin | 34.3% |
| Debt-to-Asset Ratio | 13.6% |
| Months of Reserves | 36.7 months |
Financial Health Grade: A
In 2023, Delaware Bioscience Association Inc reported a surplus of $339K with revenue exceeding expenses, holds 36.7 months of operating reserves (strong position), has a debt-to-asset ratio of 13.6% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Delaware Bioscience Association Inc's revenue has grown at a compound annual growth rate (CAGR) of 11.3%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +20.6% | +44.3% | +31.1% |
| 2022 | +50.4% | +15.3% | +36.1% |
| 2021 | -3.1% | -3.2% | +16.9% |
| 2020 | +1.9% | -0.1% | +25.7% |
| 2019 | +16.5% | -10.2% | +20.0% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2006 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Delaware Bioscience Association Inc with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 80%
- fundraising: 5%
According to IRS 990 filings, Delaware Bioscience Association Inc allocates its expenses as follows: admin: 15%, programs: 80%, fundraising: 5%. With 80% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $339K, with revenue exceeding expenses.
- Debt-to-asset ratio: 13.6%.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filings, indicating that no officers received compensation from the organization. This is highly unusual for an organization with over $1 million in revenue and suggests either a volunteer leadership model or compensation is covered by a related entity, which would require further investigation for full transparency.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Delaware Bioscience Association Inc's IRS 990 filings:
- Consistent 0% officer compensation may obscure how leadership is compensated if not truly volunteer-led, potentially impacting transparency.
Strengths
The following positive indicators were identified for Delaware Bioscience Association Inc:
- Consistent and significant revenue growth over the past decade.
- Strong asset accumulation, indicating financial stability and effective management.
- Expenses consistently lower than revenue, leading to a healthy surplus.
- No reported officer compensation, suggesting a high dedication to mission or volunteer leadership.
Frequently Asked Questions about Delaware Bioscience Association Inc
Is Delaware Bioscience Association Inc a legitimate charity?
Delaware Bioscience Association Inc (EIN: 204147195) is a registered tax-exempt nonprofit based in Delaware. Our AI analysis gives it a Mission Score of 90/100. It has 13 years of IRS 990 filings on record. Total revenue: $1.0M. 1 red flag identified. 4 strengths noted. Financial health grade: A.
How does Delaware Bioscience Association Inc spend its money?
Delaware Bioscience Association Inc directs 80% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Delaware Bioscience Association Inc tax-deductible?
Delaware Bioscience Association Inc is registered as a tax-exempt nonprofit (EIN: 204147195). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Delaware Bioscience Association Inc CEO make?
Delaware Bioscience Association Inc's highest-compensated officer earns $1 annually. The organization reported $1.0M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Delaware Bioscience Association Inc's spending goes to programs?
Delaware Bioscience Association Inc directs 80% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Delaware Bioscience Association Inc compare to similar nonprofits?
With a transparency score of 90/100 (Excellent), Delaware Bioscience Association Inc is above average for NTEE category S46 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Delaware Bioscience Association Inc located?
Delaware Bioscience Association Inc is headquartered in Wilmington, Delaware and files with the IRS under EIN 204147195. It is classified under NTEE code S46.
How many years of IRS 990 filings does Delaware Bioscience Association Inc have?
Delaware Bioscience Association Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $1.0M in total revenue.
Is Delaware Bioscience Association Inc a good charity?
Based on the provided financial data, the Delaware Bioscience Association Inc appears to be a financially healthy and well-managed organization. It demonstrates consistent revenue growth, strong asset accumulation, and a notable commitment to not paying officer compensation, which suggests a high dedication to its mission.
How has the organization's revenue changed over time?
The organization's revenue has shown significant and consistent growth, increasing from $483,663 in 2014 to $986,022 in 2023, nearly doubling in a decade.
What is the trend in the organization's assets?
Assets have steadily increased from $412,791 in 2014 to $1,981,238 in 2023, indicating strong financial growth and accumulation of resources.
Filing History
IRS 990 filing history for Delaware Bioscience Association Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Delaware Bioscience Association Inc's revenue has grown by 262.7%, moving from $272K to $986K. Total assets increased by 1030.5% over the same period, from $175K to $2.0M. Total functional expenses rose by 136.4%, from $274K to $647K. In its most recent filing year (2023), Delaware Bioscience Association Inc reported a surplus of $339K, with revenue exceeding expenses. The organization holds $270K in liabilities against $2.0M in assets (debt-to-asset ratio: 13.6%), resulting in net assets of $1.7M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $986K | $647K | $2.0M | $270K | — | View 990 |
| 2022 | $818K | $449K | $1.5M | $167K | — | View 990 |
| 2021 | $544K | $389K | $1.1M | $132K | — | View 990 |
| 2020 | $561K | $402K | $950K | $120K | — | — |
| 2019 | $551K | $402K | $756K | $84K | — | View 990 |
| 2018 | $473K | $448K | $630K | $91K | — | View 990 |
| 2017 | $475K | $388K | $599K | $85K | — | View 990 |
| 2016 | $444K | $396K | $569K | $141K | — | View 990 |
| 2015 | $488K | $378K | $506K | $127K | — | View 990 |
| 2014 | $484K | $388K | $413K | $143K | — | View 990 |
| 2013 | $395K | $330K | $285K | $111K | — | View 990 |
| 2012 | $315K | $291K | $200K | $91K | — | View 990 |
| 2011 | $272K | $274K | $175K | $28K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $986K, expenses of $647K, and assets of $2.0M (revenue +20.6% year-over-year).
- 2022: Revenue of $818K, expenses of $449K, and assets of $1.5M (revenue +50.4% year-over-year).
- 2021: Revenue of $544K, expenses of $389K, and assets of $1.1M (revenue -3.1% year-over-year).
- 2020: Revenue of $561K, expenses of $402K, and assets of $950K (revenue +1.9% year-over-year).
- 2019: Revenue of $551K, expenses of $402K, and assets of $756K (revenue +16.5% year-over-year).
- 2018: Revenue of $473K, expenses of $448K, and assets of $630K (revenue -0.4% year-over-year).
- 2017: Revenue of $475K, expenses of $388K, and assets of $599K (revenue +6.8% year-over-year).
- 2016: Revenue of $444K, expenses of $396K, and assets of $569K (revenue -8.9% year-over-year).
- 2015: Revenue of $488K, expenses of $378K, and assets of $506K (revenue +0.8% year-over-year).
- 2014: Revenue of $484K, expenses of $388K, and assets of $413K (revenue +22.3% year-over-year).
- 2013: Revenue of $395K, expenses of $330K, and assets of $285K (revenue +25.7% year-over-year).
- 2012: Revenue of $315K, expenses of $291K, and assets of $200K (revenue +15.7% year-over-year).
- 2011: Revenue of $272K, expenses of $274K, and assets of $175K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Delaware Bioscience Association Inc:
Data Sources and Methodology
This transparency report for Delaware Bioscience Association Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.